Literature DB >> 6174672

Cellular immunity to Bacteroides fragilis capsular polysaccharide.

M E Shapiro, A B Onderdonk, D L Kasper, R W Finberg.   

Abstract

The polysaccharide capsule of Bacteroides fragilis has been shown to be important in the virulence of the organism. The capsular polysaccharide (CP) of B. fragilis has been extensively purified. Using a murine model of intraabdominal abscess formation, we have been able to demonstrate cellular immunity to the capsular polysaccharide of B. fragilis. Immunization of C57BL/10J mice with the CP over 5 wk prevents abscess formation when the mice are challenged with B. fragilis intraperitoneally. This immunity can be transferred to naive mice with spleen cells from immune animals. The immune cells bear Thy-1.2 and Ly-2.2 antigens. The immune response has been shown to be antigen specific, but not H-2 restricted. The possibility that these immune cells are suppressor T cells is discussed. The experimental system presented provides a model for the examination of the cellular interactions responsible for abscess formation and the cellular response to bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174672      PMCID: PMC2186655          DOI: 10.1084/jem.155.4.1188

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

3.  Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott; R F Barth
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

4.  Abdominal trauma, anaerobes, and antibiotics.

Authors:  H Thadepalli; S L Gorbach; P W Broido; J Norsen; L Nyhus
Journal:  Surg Gynecol Obstet       Date:  1973-08

5.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

6.  Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.

Authors:  H Braley-Mullen
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

7.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

8.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

9.  Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.

Authors:  D L Kasper; A B Onderdonk; J G Bartlett
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

10.  Experimental intra-abdominal abscesses in rats: development of an experimental model.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  31 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 3.  Virulence factors in anaerobic bacteria.

Authors:  T Hofstad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

4.  Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection.

Authors:  Erin B Troy; Vincent J Carey; Dennis L Kasper; Laurie E Comstock
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

5.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.

Authors:  D F Zaleznik; R W Finberg; M E Shapiro; A B Onderdonk; D L Kasper
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

7.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

8.  Phenolic glycolipid 1 of Mycobacterium leprae causes nonspecific inflammation but has no effect on cell-mediated responses in mice.

Authors:  S J Brett; C Lowe; S N Payne; P Draper
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Cellular and humoral immune response to a phenolic glycolipid antigen (PhenGL-I) in patients with leprosy.

Authors:  F T Koster; D M Scollard; E T Umland; D B Fishbein; W C Hanly; P J Brennan; K E Nelson
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.